Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

NCT04323189 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Genetics Disease
Type2 Diabetes
Heart Failure

Interventions

DRUG: Sitagliptin 100mg
DRUG: Placebo Oral Tablet

Sponsor

University of Pennsylvania